| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 1061 | 2017 |
| Systematic review: predicting and optimising response to anti‐TNF therapy in Crohn's disease–algorithm for practical management NS Ding, A Hart, P De Cruz Alimentary pharmacology & therapeutics 43 (1), 30-51, 2016 | 316 | 2016 |
| Systematic review with meta‐analysis: faecal diversion for management of perianal Crohn's disease S Singh, NS Ding, KL Mathis, PS Dulai, AM Farrell, JH Pemberton, ... Alimentary pharmacology & therapeutics 42 (7), 783-792, 2015 | 179 | 2015 |
| Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study CHR Choi, I Al Bakir, NSJ Ding, GH Lee, A Askari, J Warusavitarne, ... Gut 68 (3), 414-422, 2019 | 157 | 2019 |
| Relapse after withdrawal from anti‐TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta‐analysis NA Kennedy, B Warner, EL Johnston, L Flanders, P Hendy, NS Ding, ... Alimentary pharmacology & therapeutics 43 (8), 910-923, 2016 | 116 | 2016 |
| The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis M Garg, P Hendy, JN Ding, S Shaw, G Hold, A Hart Journal of Crohn's and Colitis 12 (8), 963-972, 2018 | 112 | 2018 |
| Systematic review with meta‐analysis: the management of chronic refractory pouchitis with an evidence‐based treatment algorithm JP Segal, NS Ding, G Worley, S Mclaughlin, S Preston, OD Faiz, SK Clark, ... Alimentary Pharmacology & Therapeutics 45 (5), 581-592, 2017 | 112 | 2017 |
| European Crohn’s and Colitis Organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease J Torres, P Ellul, J Langhorst, A Mikocka-Walus, M Barreiro-de Acosta, ... Journal of Crohn's and Colitis 13 (6), 673-685e, 2019 | 111 | 2019 |
| Liver stiffness plus platelet count can be used to exclude high‐risk oesophageal varices NS Ding, T Nguyen, DM Iser, T Hong, E Flanagan, A Wong, L Luiz, ... Liver International 36 (2), 240-245, 2016 | 103 | 2016 |
| NUDT 15 polymorphisms are better than thiopurine S‐methyltransferase as predictor of risk for thiopurine‐induced leukopenia in Chinese patients with Crohn's disease X Zhu, XD Wang, K Chao, M Zhi, H Zheng, HL Ruan, S Xin, N Ding, PJ Hu, ... Alimentary pharmacology & therapeutics 44 (9), 967-975, 2016 | 100 | 2016 |
| Management of inflammatory bowel disease. EK Wright, NS Ding, O Niewiadomski The Medical Journal of Australia 209 (7), 318-323, 2018 | 90 | 2018 |
| Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China P An, M Ji, H Ren, J Su, NS Ding, J Kang, A Yin, Q Zhou, L Shen, L Zhao, ... The Lancet Gastroenterology & Hepatology 5 (6), 525-527, 2020 | 89 | 2020 |
| Prospective population‐based cohort of inflammatory bowel disease in the biologics era: disease course and predictors of severity O Niewiadomski, C Studd, C Hair, J Wilson, NS Ding, N Heerasing, A Ting, ... Journal of gastroenterology and hepatology 30 (9), 1346-1353, 2015 | 87 | 2015 |
| Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised … L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ... The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022 | 78 | 2022 |
| Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials DT Rubin, I Dotan, A DuVall, Y Bouhnik, G Radford-Smith, PDR Higgins, ... The lancet Gastroenterology & hepatology 7 (1), 17-27, 2022 | 70 | 2022 |
| Endoscopic dilatation of Crohn’s anastomotic strictures is effective in the long term, and escalation of medical therapy improves outcomes in the biologic era NS Ding, WM Yip, CH Choi, B Saunders, S Thomas-Gibson, N Arebi, ... Journal of Crohn's and Colitis 10 (10), 1172-1178, 2016 | 66 | 2016 |
| The body composition profile is associated with response to anti‐TNF therapy in Crohn's disease and may offer an alternative dosing paradigm NS Ding, G Malietzis, PFC Lung, L Penez, WM Yip, S Gabe, JT Jenkins, ... Alimentary pharmacology & therapeutics 46 (9), 883-891, 2017 | 62 | 2017 |
| Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease F Cordes, D Foell, JN Ding, G Varga, D Bettenworth World journal of gastroenterology 26 (28), 4055, 2020 | 60 | 2020 |
| Quantitative phase microscopy for evaluation of intestinal inflammation and wound healing utilizing label-free biophysical markers D Bettenworth, A Bokemeyer, C Poremba, NS Ding, S Ketelhut, P Lenz, ... Universidad de Murcia. Departamento de Biología Celular e Histología, 2018 | 52 | 2018 |
| Efficacy of endoscopic dilation of gastroduodenal Crohn’s disease strictures: a systematic review and meta-analysis of individual patient data D Bettenworth, MM Mücke, R Lopez, A Singh, W Zhu, F Guo, T Matsui, ... Clinical Gastroenterology and Hepatology 17 (12), 2514-2522. e8, 2019 | 44 | 2019 |
